Company profile for Medunik

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Medunik USA is dedicated to providing Americans suffering from rare diseases with access to orphan drugs that are not currently available in the U.S. We make these treatment options available by building strategic partnerships with international companies to bring their products to the American market. Through in-licensing partnerships, Medunik USA offers turn-key operations and provides medical scientific liaisons, approval a...
Medunik USA is dedicated to providing Americans suffering from rare diseases with access to orphan drugs that are not currently available in the U.S. We make these treatment options available by building strategic partnerships with international companies to bring their products to the American market. Through in-licensing partnerships, Medunik USA offers turn-key operations and provides medical scientific liaisons, approval and market access processes, and marketing for orphan disease treatments. Medunik USA is part of the Duchesnay group, which consists of five pharmaceutical companies.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
2 Research Way Suite 1B Princeton, NJ 08540
Telephone
Telephone
+1 8446338645
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

BPI Europe

BPI Europe

Not Confirmed

envelop Contact Supplier

BPI Europe

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/medunik-usa-reaffirms-support-for-sickle-cell-disease-community-with-uninterrupted-supply-and-patient-centered-services-302617704.html

PR NEWSWIRE
18 Nov 2025

https://www.prnewswire.com/news-releases/medunik-usa-strengthens-pheburane-sodium-phenylbutyrate-coverage-under-medicaid-programs-302603156.html

PR NEWSWIRE
04 Nov 2025

https://www.prnewswire.com/news-releases/medunik-usa-expands-siklos-hydroxyurea-coverage-under-medicaid-programs-to-37-states-302509990.html

PR NEWSWIRE
22 Jul 2025

https://www.prnewswire.com/news-releases/medunik-usa-expands-medicaid-coverage-and-patient-support-services-for-pheburane-sodium-phenylbutyrate-302249624.html

PR NEWSWIRE
17 Sep 2024

https://www.prnewswire.com/news-releases/medunik-usas-unik-support-program-for-pheburane-expands-to-now-include-2-specialty-pharmacy-options-302162640.html

PR NEWSWIRE
04 Jun 2024

https://www.globenewswire.com//news-release/2023/10/26/2767387/0/en/Pheburane-sodium-phenylbutyrate-coverage-to-reach-80-of-commercially-insured-US-patients-by-January-1st-2024.html

GLOBENEWSWIRE
26 Oct 2023

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty